Log In Sign up
The largest database of trusted experimental protocols

Amg 511

Manufactured by Selleck Chemicals
Visit Supplier

The AMG 511 is a laboratory instrument designed for the analysis and measurement of various chemical compounds. It utilizes advanced analytical techniques to provide accurate and reliable data. The core function of the AMG 511 is to facilitate the identification and quantification of substances within a sample.

Automatically generated - may contain errors

Lab products found in correlation

Alectinib, by Selleck Chemicals (2 mentions) Lorlatinib, by Selleck Chemicals (2 mentions) Sotorasib, by Selleck Chemicals (2 mentions) Adagrasib, by Selleck Chemicals (2 mentions) Afatinib, by Selleck Chemicals (2 mentions) Osimertinib, by Selleck Chemicals (2 mentions) Crizotinib, by Selleck Chemicals (2 mentions) Erlotinib, by Selleck Chemicals (2 mentions) Azd5363, by Selleck Chemicals (2 mentions) Gefitinib, by Selleck Chemicals (2 mentions) Trametinib, by Selleck Chemicals (2 mentions) Rmc 4550, by Selleck Chemicals (2 mentions)

2 protocols using amg 511

1

Targeted Therapies in Cancer Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following targeted therapies were used in this study: erlotinib, gefitinib, osimertinib, crizotinib, alectinib, lorlatinib, sotorasib, and adagrasib (Selleckchem). MAPK pathway inhibitors included afatinib, erlotinib, RMC-4550, sotorasib, trametinib, AMG 511, and AZD5363 (Selleckchem).
Vaccaro K., Allen J., Whitfield T.W., Maoz A., Reeves S., Velarde J., Yang D., Meglan A., Ribeiro J., Blandin J., Phan N., Bell G.W., Hata A.N, & Weiskopf K. (2024). Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction. The Journal of Clinical Investigation, 134(9), e169315.
+ Open protocol
+ Expand
2

Targeted Therapies and MAPK Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following targeted therapies were used in this study: erlotinib, gefitinib, osimertinib, crizotinib, alectinib, lorlatinib, sotorasib, adagrasib (Selleckchem). MAPK pathway inhibitors included: afatinib, erlotinib, RMC-4550, sotorasib, trametinib, AMG 511, AZD5363 (Selleckchem).
Vaccaro K., Allen J., Whitfield T.W., Maoz A., Reeves S., Velarde J., Yang D., Phan N., Bell G.W., Hata A.N, & Weiskopf K. (2023). Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction. bioRxiv.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!